1.
Bioorg Med Chem Lett
; 20(17): 5212-6, 2010 Sep 01.
Article
in English
| MEDLINE
| ID: mdl-20655214
ABSTRACT
The union of HCV-796, a potent selective HCV NS5B polymerase inhibitor, and Ribavirin, a molecule with activities against a wide spectrum of viruses, resulted in a class of new anti-HCV agents with a sequential triple inhibitory mechanism.
